Education
About Us
Working with TipRanks
Follow Us
Sihuan Pharmaceutical Holdings Group Ltd. (HK:0460)
:0460
RESEARCH TOOLSreports
0460 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.50 - HK$1.44
Previous CloseN/A
Volume8.01M
Average Volume (3M)99.96M
Market Cap
$12.13B
Enterprise ValueHK$3.64B
Total Cash (Recent Filing)$3.63B
Total Debt (Recent Filing)$942.76M
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Sep 02, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 27, 2024Dividend Yield1.62%
Share Statistics
EPS (TTM)-0.02
Shares Outstanding9,329,999,000
10 Day Avg. Volume76,314,825
30 Day Avg. Volume99,959,260
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.30
Enterprise Value/Revenue1.92
Enterprise Value/Gross Profit2.93
Enterprise Value/Ebitda-17.45
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sihuan Pharmaceutical Holdings Group News
0460 FAQ
What was Sihuan Pharmaceutical Holdings Group Ltd.’s price range in the past 12 months?
Sihuan Pharmaceutical Holdings Group Ltd. lowest stock price was HK$0.49 and its highest was HK$1.44 in the past 12 months.
What is Sihuan Pharmaceutical Holdings Group Ltd.’s market cap?
Sihuan Pharmaceutical Holdings Group Ltd.’s market cap is $12.13B.
When is Sihuan Pharmaceutical Holdings Group Ltd.’s upcoming earnings report date?
Sihuan Pharmaceutical Holdings Group Ltd.’s upcoming earnings report date is Sep 02, 2025 which is in 30 days.
How were Sihuan Pharmaceutical Holdings Group Ltd.’s earnings last quarter?
Sihuan Pharmaceutical Holdings Group Ltd. released its earnings results on Mar 28, 2025. The company reported -HK$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.022.
Is Sihuan Pharmaceutical Holdings Group Ltd. overvalued?
According to Wall Street analysts Sihuan Pharmaceutical Holdings Group Ltd.’s price is currently Overvalued.
Does Sihuan Pharmaceutical Holdings Group Ltd. pay dividends?
Sihuan Pharmaceutical Holdings Group Ltd. pays a Notavailable dividend of HK$0.021 which represents an annual dividend yield of 1.62%. See more information on Sihuan Pharmaceutical Holdings Group Ltd. dividends here
What is Sihuan Pharmaceutical Holdings Group Ltd.’s EPS estimate?
Sihuan Pharmaceutical Holdings Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sihuan Pharmaceutical Holdings Group Ltd. have?
Sihuan Pharmaceutical Holdings Group Ltd. has 9,329,999,000 shares outstanding.
What happened to Sihuan Pharmaceutical Holdings Group Ltd.’s price movement after its last earnings report?
Sihuan Pharmaceutical Holdings Group Ltd. reported an EPS of -HK$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sihuan Pharmaceutical Holdings Group Ltd.?
Currently, no hedge funds are holding shares in HK:0460
Sihuan Pharmaceutical Holdings Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
61.29%
12-Months-Change
Fundamentals
Return on Equity
-4.93%
Trailing 12-Months
Asset Growth
-11.29%
Trailing 12-Months
Company Description
Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.
Technical Analysis
China Traditional Chinese Medicine Holdings Co
―
Consun Pharmaceutical Group Ltd.
―
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
―
CanSino Biologics, Inc. Class H
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―
Ownership Overview
―
Insiders
2.19%
Mutual Funds
<0.01% Other Institutional Investors
95.85% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---